Akums Drugs and Pharmaceutical Total Liabilities

Latest as of March 2026: Rs21.16 Billion INR ≈ $228.82 Million USD

Akums Drugs and Pharmaceutical total liabilities. Based on the latest financial reports, Akums Drugs and Pharmaceutical (AKUMS) has total liabilities worth Rs21.16 Billion INR (≈ $228.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Akums Drugs and Pharmaceutical to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Akums Drugs and Pharmaceutical (2022–2026)

Total liabilities of Akums Drugs and Pharmaceutical from 2022 to 2026. This chart illustrates how Akums Drugs and Pharmaceutical's total liabilities have evolved over time, based on quarterly financial data.

Akums Drugs and Pharmaceutical Competitors by Total Liabilities

The table below lists competitors of Akums Drugs and Pharmaceutical ranked by their total liabilities.

Company	Country	Total Liabilities
Shenzhen Noposion Agrochemicals Co Ltd SHE:002215	China	CN¥7.29 Billion
Wuxi Paike New Materials Technology Co Ltd SHG:605123	China	CN¥4.24 Billion
BioGaia AB (publ) ST:BIOG-B	Sweden	Skr235.14 Million
Hanall Biopharma KO:009420	Korea	₩44.17 Billion
FLEX LNG Ltd F:0QQA	Germany	€1.94 Billion
Preferred Bank NASDAQ:PFBC	USA	$6.94 Billion
ATRESM.C.D.M.ADR/1/EO-75 F:YT2	Germany	€745.49 Million
Lloyds Engineering Works Limited NSE:LLOYDSENGG	India	Rs6.86 Billion

Liability Composition Analysis (2022–2026)

This chart breaks down Akums Drugs and Pharmaceutical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Akums Drugs and Pharmaceutical balance sheet assets.

Liquidity & Leverage Metrics

Akums Drugs and Pharmaceutical Total Liabilities Ratios Explained

Akums Drugs and Pharmaceutical total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Akums Drugs and Pharmaceutical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Akums Drugs and Pharmaceutical (2022–2026)

The table below shows the annual total liabilities of Akums Drugs and Pharmaceutical from 2022 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs21.16 Billion ≈ $228.82 Million	+101.54%
2025-03-31	Rs10.50 Billion ≈ $113.54 Million	-62.45%
2024-03-31	Rs27.96 Billion ≈ $302.36 Million	+9.94%
2023-03-31	Rs25.43 Billion ≈ $275.03 Million	+4.06%
2022-03-31	Rs24.44 Billion ≈ $264.30 Million	--

About Akums Drugs and Pharmaceutical

NSE:AKUMS India Drug Manufacturers - Specialty & Generic

Market Cap

$1.26 Billion

Rs116.53 Billion INR

Market Cap Rank

#7655 Global

#377 in India

Share Price

Rs761.15

Change (1 day)

+3.82%

52-Week Range

Rs414.05 - Rs823.30

All Time High

Rs1119.95